252 related articles for article (PubMed ID: 20733534)
41. [Heart transplantation in AL amyloidosis].
Dahlberg P; Bartfay SE; Karason K; Mellqvist UH; Bollano E
Lakartidningen; 2018 Mar; 115():. PubMed ID: 29583159
[TBL] [Abstract][Full Text] [Related]
42. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
Lacy MQ; Dispenzieri A; Hayman SR; Kumar S; Kyle RA; Rajkumar SV; Edwards BS; Rodeheffer RJ; Frantz RP; Kushwaha SS; Clavell AL; Dearani JA; Sundt TM; Daly RC; McGregor CG; Gastineau DA; Litzow MR; Gertz MA
J Heart Lung Transplant; 2008 Aug; 27(8):823-9. PubMed ID: 18656793
[TBL] [Abstract][Full Text] [Related]
43. Deferred autologous stem cell transplantation in systemic AL amyloidosis.
Manwani R; Hegenbart U; Mahmood S; Sachchithanantham S; Kyriakou C; Yong K; Popat R; Rabin N; Whelan C; Dittrich T; Kimmich C; Hawkins P; Schönland S; Wechalekar A
Blood Cancer J; 2018 Nov; 8(11):101. PubMed ID: 30397193
[TBL] [Abstract][Full Text] [Related]
44. Outcomes of autologous stem cell transplant for cardiac AL-amyloidosis and cardiac light chain deposition disease.
Abdallah AA; Alapat D; Kaur V; Atrash S
J Oncol Pharm Pract; 2020 Jul; 26(5):1128-1133. PubMed ID: 31795821
[TBL] [Abstract][Full Text] [Related]
45. Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis.
Leung N; Dispenzieri A; Fervenza FC; Lacy MQ; Villicana R; Cavalcante JL; Gertz MA
Am J Kidney Dis; 2005 Aug; 46(2):270-7. PubMed ID: 16112045
[TBL] [Abstract][Full Text] [Related]
46. Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients.
Moreau P; Leblond V; Bourquelot P; Facon T; Huynh A; Caillot D; Hermine O; Attal M; Hamidou M; Nedellec G; Ferrant A; Audhuy B; Bataille R; Milpied N; Harousseau JL
Br J Haematol; 1998 Jun; 101(4):766-9. PubMed ID: 9674753
[TBL] [Abstract][Full Text] [Related]
47. Autologous stem cell transplantation in light-chain amyloidosis patients: a single-center experience in Korea.
Kim SJ; Lee GY; Jang HR; Choi JO; Kim JS; Kim HJ; Lee SY; Min JH; Jeon ES; Kim K
Amyloid; 2013 Dec; 20(4):204-11. PubMed ID: 23914780
[TBL] [Abstract][Full Text] [Related]
48. Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis.
Gray Gilstrap L; Niehaus E; Malhotra R; Ton VK; Watts J; Seldin DC; Madsen JC; Semigran MJ
J Heart Lung Transplant; 2014 Feb; 33(2):149-56. PubMed ID: 24200511
[TBL] [Abstract][Full Text] [Related]
49. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients.
Comenzo RL; Vosburgh E; Simms RW; Bergethon P; Sarnacki D; Finn K; Dubrey S; Faller DV; Wright DG; Falk RH; Skinner M
Blood; 1996 Oct; 88(7):2801-6. PubMed ID: 8839879
[TBL] [Abstract][Full Text] [Related]
50. Autologous Stem Cell Transplantation in Patients With Primary Systemic Amyloidosis: Experience of a Tertiary Hospital.
Domínguez-Muñoz MA; Calderón-Cabrera C; Martino-Galiana ML; Martín-Sánchez J
Transplant Proc; 2015 Nov; 47(9):2661-4. PubMed ID: 26680066
[TBL] [Abstract][Full Text] [Related]
51. Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosis.
Gertz MA; Lacy MQ; Dispenzieri A; Buadi FK; Dingli D; Hayman SR; Kumar SK; Leung N; Lust J; Rajkumar SV; Russell SJ; Suman VJ; Le-Rademacher JG; Hogan WJ
Cancer; 2016 Jul; 122(14):2197-205. PubMed ID: 27142462
[TBL] [Abstract][Full Text] [Related]
52. Emerging therapy in light-chain and acquired transthyretin-related amyloidosis: an Italian single-centre experience in heart transplantation.
Di Nora C; Sponga S; Ferrara V; Patriarca F; Fanin R; Nalli C; Lechiancole A; Vendramin I; Livi U
J Cardiovasc Med (Hagerstown); 2021 Apr; 22(4):261-267. PubMed ID: 33633041
[TBL] [Abstract][Full Text] [Related]
53. High-dose therapy and autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis: a Center for International Blood and Marrow Transplant Research Study.
Vesole DH; Pérez WS; Akasheh M; Boudreau C; Reece DE; Bredeson CN;
Mayo Clin Proc; 2006 Jul; 81(7):880-8. PubMed ID: 16835967
[TBL] [Abstract][Full Text] [Related]
54. Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis.
Perz JB; Rahemtulla A; Giles C; Szydlo RM; Davis J; Gopaul D; Gillmore J; Mathias CJ; Hawkins PN; Apperley JF
Bone Marrow Transplant; 2006 May; 37(10):937-43. PubMed ID: 16565738
[TBL] [Abstract][Full Text] [Related]
55. Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management.
Estep JD; Bhimaraj A; Cordero-Reyes AM; Bruckner B; Loebe M; Torre-Amione G
Methodist Debakey Cardiovasc J; 2012; 8(3):8-16. PubMed ID: 23227279
[TBL] [Abstract][Full Text] [Related]
56. [Prognostic factors in light chain amyloidosis].
Jávorniczky NR; Bodó I; Masszi T; Mikala G
Orv Hetil; 2015 Sep; 156(39):1577-84. PubMed ID: 26550915
[TBL] [Abstract][Full Text] [Related]
57. Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Fuchida SI; Kawamura K; Sunami K; Tsukada N; Fujii S; Ohkawara H; Usuki K; Wake A; Endo S; Ishiyama K; Ueda Y; Nakamura Y; Miyamoto T; Fukuda T; Ichinohe T; Atsuta Y; Takamatsu H
Transplant Cell Ther; 2022 Feb; 28(2):76-82. PubMed ID: 34774818
[TBL] [Abstract][Full Text] [Related]
58. Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis.
Gillmore JD; Goodman HJ; Lachmann HJ; Offer M; Wechalekar AD; Joshi J; Pepys MB; Hawkins PN
Blood; 2006 Feb; 107(3):1227-9. PubMed ID: 16210334
[TBL] [Abstract][Full Text] [Related]
59. Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75.
Sidiqi MH; Aljama MA; Muchtar E; Buadi FK; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Leung N; Gonsalves WI; Kapoor P; Kourelis TV; Hogan WJ; Kumar SK; Gertz MA
Biol Blood Marrow Transplant; 2018 Oct; 24(10):2157-2159. PubMed ID: 29933071
[TBL] [Abstract][Full Text] [Related]
60. Primary systemic amyloidosis.
Comenzo RL
Curr Treat Options Oncol; 2000 Apr; 1(1):83-9. PubMed ID: 12057064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]